Curative Biotech Competitors and Similar CompaniesClear all

Curative Biotech's competitors and similar companies include ImmunoCellular Therapeutics, Vascular BioSciences, BioInvent and Calviri.

	Curative Biotech Curative Biotech (formerly known as Frozen Assets, Growth Industries, Fragrance Express, National Boston Medical, Storage Innovation Technologies, Connectyx Technologies Holdings Group) is a biopharmaceutical company engaging in the development of therapeutics, medical devices, or diagnostics of rare diseases.	ImmunoCellular Therapeutics ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.	Vascular BioSciences Vascular BioSciences (VBS) is a biopharmaceutical and medical device company focused on cardiovascular and inflammatory diseases.	BioInvent BioInvent focuses on the discovery and development of antibody-based drugs against cancer.	Calviri Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer.
Founding Date	Founding Date 1995	Founding Date 2006	Founding Date 1995	Founding Date 1997	Founding Date 2018
Type	Type Public	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech drug development medical devices medical diagnostics oncology pharma	Tags Healthcare biotech clinical research drug development healthtech medical devices medical diagnostics oncology pharma therapy	Tags Healthcare biotech drug development medical devices medical diagnostics medtech oncology pharma	Tags Healthcare biotech drug development medical diagnostics oncology pharma	Tags Healthcare biotech drug development medical diagnostics oncology pharma
Locations	Locations Boca Raton, US HQ	Locations Calabasas, US HQ	Locations Goleta, US HQ Durham, US	Locations Lund, SE HQ	Locations Phoenix, US HQ
Employees	Employees 4	Employees 357% decrease	Employees 267% decrease	Employees 118	Employees 16
Valuation ($)	Valuation ($) 9 m	Valuation ($) 15.9 m	Valuation ($) N/A	Valuation ($) 285.9 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr226.5m (FY, 2025)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($14.3m) (FY, 2017)	Net income N/A	Net income (kr332.9m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 32.5m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 2.3m